KLK3 and cancer: The proposed rational decision was to sacrifice sensitivity and to recruit as much patients for active surveillance as possible, bearing in mind that those who have significant cancer will be predominantly censored at follow-up biopsy, or according to PSA dynamics without any significant risks of being late for radical treatment, due to slow progression of prostate cancer [4].